Natixis Prestige Consumer Healthcare Inc. Transaction History
Natixis
- $16 Billion
- Q4 2024
A detailed history of Natixis transactions in Prestige Consumer Healthcare Inc. stock. As of the latest transaction made, Natixis holds 280 shares of PBH stock, worth $24,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
280
Previous 247
13.36%
Holding current value
$24,080
Previous $17,000
23.53%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding PBH
# of Institutions
357Shares Held
52.4MCall Options Held
6.3KPut Options Held
0-
Black Rock Inc. New York, NY8.28MShares$712 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.69MShares$489 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.91MShares$250 Million0.06% of portfolio
-
Ariel Investments, LLC Chicago, IL2.76MShares$238 Million2.55% of portfolio
-
Macquarie Group LTD Australia, C32.31MShares$199 Million0.21% of portfolio
About Prestige Consumer Healthcare Inc.
- Ticker PBH
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,762,600
- Market Cap $4.28B
- Description
- Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...